Elekta AB Stock price

Equities

EKTA B

SE0000163628

Advanced Medical Equipment & Technology

Delayed Nasdaq Stockholm 07:59:31 2024-03-28 am EDT 5-day change 1st Jan Change
80.7 SEK -0.15% Intraday chart for Elekta AB +1.56% -1.97%
Sales 2024 * 18.22B 1.71B Sales 2025 * 19.23B 1.8B Capitalization 30.88B 2.89B
Net income 2024 * 1.49B 139M Net income 2025 * 1.85B 173M EV / Sales 2024 * 1.86 x
Net Debt 2024 * 3.02B 283M Net Debt 2025 * 2.63B 246M EV / Sales 2025 * 1.74 x
P/E ratio 2024 *
20.8 x
P/E ratio 2025 *
16.7 x
Employees 4,584
Yield 2024 *
3.15%
Yield 2025 *
3.53%
Free-Float 89.83%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.42%
1 week+2.27%
Current month+8.43%
1 month+10.44%
3 months-0.29%
6 months+10.47%
Current year-1.29%
More quotes
1 week
78.88
Extreme 78.88
81.62
1 month
70.00
Extreme 70
81.62
Current year
70.00
Extreme 70
85.86
1 year
70.00
Extreme 70
90.42
3 years
53.24
Extreme 53.24
132.35
5 years
53.24
Extreme 53.24
145.45
10 years
50.25
Extreme 50.25
145.45
More quotes
Managers TitleAgeSince
Founder 72 71-12-31
Chief Executive Officer 47 08-12-31
Director of Finance/CFO 46 22-01-31
Members of the board TitleAgeSince
Founder 72 71-12-31
Director/Board Member 67 10-06-29
Director/Board Member 67 04-12-31
More insiders
Date Price Change Volume
24-03-28 80.7 -0.15% 380 508
24-03-27 80.82 +0.25% 526,575
24-03-26 80.62 -0.07% 568,200
24-03-25 80.68 +0.72% 610,114
24-03-22 80.1 +0.81% 1,074,314

Delayed Quote Nasdaq Stockholm, March 28, 2024 at 07:05 am EDT

More quotes
Elekta publ AB is a Sweden-based human care company that develops and sells clinical solutions for the treatment of cancer and brain disorder. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. The Company has four product areas: Elekta Neuroscience, which develops solutions for the diagnosis and treatment of neurological diseases; Elekta Oncology, which creates clinical solutions for radiation therapy, such as linear accelerators, integrated imaging systems and clinical solutions for patient positioning and immobilization; Elekta Brachytherapy, which is engaged in the treatment of cancer through internal radiation, and Elekta Software, which develops software solutions for patient information, workflow management and treatment planning in oncology. The Company owns the service business of Asesores Electronicos Especializados SA de CV (AEESA).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
80.82 SEK
Average target price
86 SEK
Spread / Average Target
+6.41%
Consensus
  1. Stock
  2. Equities
  3. Stock Elekta AB - Nasdaq Stockholm